MAGEA11 and gastric cancer: In contrast, the upregulation of MAGEA11, a member of the MAGE family, in GC has been shown to be significantly associated with lower survival rates and immune infiltration, suggesting that MAGEA11 may be a potential biomarker and therapeutic target in GC 23.